CD33 and neoplasm: CD33-expressing tumor cells were effectively targeted and lysed by anti-E3–anti-CD33 and anti-E3–anti-CD123-activated SAR T cells, but not unt T cells (Fig. 2A and Supplementary Fig. 2C).